HepaGam B (Cangene bioPharma Inc.)


Welcome to the PulseAid listing for the HepaGam B drug offered from Cangene bioPharma Inc.. This Human Immunoglobulin [EPC],Passively Acquired Immunity [PE],Virus Neutralization [MoA],Virus-specific Hyperimmune Globulins [Chemical/Ingredient],Immunoglobulins [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.

LABELER NAME / MANUFACTURER: Cangene bioPharma Inc.
NON-PROPRIETARY NAME: Hepatitis B Immune Globulin (Human)
SUBSTANCE NAME: HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
TYPE: PLASMA DERIVATIVE
PHARMA CLASS: Human Immunoglobulin [EPC],Passively Acquired Immunity [PE],Virus Neutralization [MoA],Virus-specific Hyperimmune Globulins [Chemical/Ingredient],Immunoglobulins [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2010-08-01
END MARKETING DATE: 0000-00-00


HepaGam B PLASMA DERIVATIVE Details:

Item DescriptionHepaGam B from Cangene bioPharma Inc.
LABELER NAME: Cangene bioPharma Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 312([iU]/mL)
START MARKETING DATE: 2010-08-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 53270-0051_148e1fa7-efc7-47be-a20a-1e9a623852e2
PRODUCT NDC: 53270-0051
APPLICATION NUMBER: BLA125035

Other HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Aptevo BioTherapeutics LLCHepaGam B
Biotest Pharmaceuticals CorporationNABI-HB
Cangene bioPharma Inc.HepaGam B
Cangene BioPharma, LLCHepaGam B
GRIFOLS USA, LLCHYPERHEP B